ARTICLE | Company News
Novactyl, Upsher-Smith deal
October 7, 2002 7:00 AM UTC
Upsher-Smith received exclusive worldwide development and marketing rights to Novactyl's PCL-016 and FDR-488 antivirals that target zinc finger proteins (ZFPs) to treat cold sores and genital herpes....